Digital life sciences 

At the core of drug discovery is data, and our team is dedicated to helping you harness its power. We partner with you to implement tailored strategies for target identification, hit finding and lead optimisation, accelerating your pipeline with advanced digital technologies. As a science CRO, we recognise the challenges of drug discovery and the critical role of cutting-edge digital tools and automation. Our services span bioinformatics, molecular modeling and AI, to help ensure timely, cost-effective solutions for discovering and optimising new drug candidates.  

In the target identification stage, our data mining and ligandability analyses lay a strong foundation for your program. For hit finding and virtual screening, we leverage our proprietary life science database, external libraries and custom-designed resources. During hit-to-lead and lead optimisation, we apply advanced ligand- and structure-based molecular modelling techniques to refine promising candidates from a pool of initial hits.  

Our machine learning capabilities enable rapid identification and optimisation of drug candidates, targeting key properties such as potency, selectivity, physicochemical characteristics and DMPK profiles. With extensive experience in digital strategy design and implementation, we customise solutions to meet your project’s unique needs while integrating seamlessly with other Nuvisan capabilities, including chemistry and structural biology.  

Time and resources are critical in drug discovery. Our goal is to deliver actionable insights and results efficiently, streamlining your program and helping you design the next breakthrough therapy.